Pacira Pharmaceuticals reported $181.85M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Amerisourcebergen ABC:US USD 62.21B 1.48B
Astellas Pharma 4503:JP JPY 340.79B 47.14B
Bristol Myers Squibb BMY:US USD 9.46B 716M
Cara Therapeutics CARA:US USD 34.57M 90K
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Horizon Pharma HZNP:US USD 768.1M 3.34M
Ironwood Pharmaceuticals IRWD:US USD 38.84M 1.33M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Ligand Pharmaceuticals LGND:US USD 70.48M 5.93M
Nektar Therapeutics NKTR:US USD 74.49M 3.43M
Pacira Pharmaceuticals PCRX:US USD 181.85M 35.67M
Perrigo Ordinary Shares PRGO:US USD 1.12B 57.6M
Pfizer PFE:US USD 19.12B 5.9B
Revance Therapeutics RVNC:US USD 194.33M 87.83M
Supernus Pharmaceuticals SUPN:US USD 132.99M 45.88M
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.31M 191K
Zoetis ZTS:US USD 1.45B 113M